GENFIT Share Price Börse Stuttgart
Stocks
XUP
FR0004163111
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Börse Stuttgart
01:26:00 12/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 12.92 EUR | -5.28% |
|
-5.69% | +153.33% |
| Market Cap | 65Cr 76Cr 62Cr 56Cr 104.87Cr 7.22TCr 105.4Cr 732.46Cr 281.66Cr 3.67TCr 283.9Cr 277.67Cr 12TCr | P/E 2026 * |
33.5x | P/E 2027 * | 74.3x |
|---|---|---|---|---|---|
| Enterprise Value | 60Cr 70Cr 57Cr 52Cr 97Cr 6.66TCr 97Cr 674.98Cr 259.56Cr 3.39TCr 261.62Cr 255.88Cr 11TCr | EV / Sales 2026 * |
5.98x | EV / Sales 2027 * | 4.67x |
| Free-Float |
86.89% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| GNFT | Real-time | |
CBOE
| GNFTp | Real-time | |
Börse Stuttgart
| XUP | Delayed | |
Tradegate
| XUP | Real-time | |
OTC Markets
| GNFTF | Delayed | |
Deutsche Boerse AG
| XUP | Delayed | |
Boerse Muenchen
| XUP | Real-time | |
Xetra
| XUP | Delayed | |
London S.E.
| 0QT6 | Delayed | |
CBOE
| 0QT6 | Real-time |
Last Transcript : GENFIT
| 1 day | -5.28% | ||
| 1 week | -5.69% | ||
| Current month | -7.71% | ||
| 1 month | +2.38% | ||
| 3 months | +44.84% | ||
| 6 months | +44.76% | ||
| Current year | +153.33% |
| 1 week | 11.8 | 14.24 | |
| 1 month | 11.8 | 14.8 | |
| Current year | 5.06 | 15.4 | |
| 1 year | 3.58 | 15.4 | |
| 3 years | 3.3 | 15.4 | |
| 5 years | 2.96 | 15.4 | |
| 10 years | 2.96 | 21.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 16/09/2019 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 22/04/2021 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 27/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 16/06/2017 | |
| Director/Board Member | 54 | 15/09/1999 | |
| Director/Board Member | 58 | 16/06/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.28% | -5.69% | - | - | 80Cr | ||
| -0.71% | -6.35% | -4.87% | +9.03% | 4.61TCr | ||
| +0.21% | -2.98% | +340.68% | +519.93% | 4.36TCr | ||
| +1.74% | -2.24% | +37.28% | +21.57% | 4.24TCr | ||
| +1.38% | -3.28% | +3.23% | +65.60% | 3.89TCr | ||
| -1.44% | -5.26% | +8.78% | +36.85% | 3.22TCr | ||
| +0.87% | -2.60% | - | - | 1.72TCr | ||
| +0.75% | -0.64% | +18.07% | +110.32% | 1.63TCr | ||
| -0.31% | -2.78% | +10.47% | +30.49% | 1.43TCr | ||
| +1.93% | -3.55% | +74.20% | +39.37% | 1.3TCr | ||
| Average | -0.09% | -4.23% | +60.98% | +104.14% | 2.93TCr | |
| Weighted average by Cap. | +0.38% | -4.51% | +73.05% | +123.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10Cr 12Cr 9.5Cr 8.61Cr 16Cr 1.11TCr 16Cr 112.78Cr 43Cr 565.73Cr 44Cr 43Cr 1.79TCr | 13Cr 15Cr 12Cr 11Cr 20Cr 1.39TCr 20Cr 141.04Cr 54Cr 707.48Cr 55Cr 53Cr 2.24TCr |
| Net income | 2.29Cr 2.66Cr 2.17Cr 1.96Cr 3.68Cr 253.67Cr 3.7Cr 26Cr 9.89Cr 129.06Cr 9.97Cr 9.75Cr 407.81Cr | 68L 78.92L 64.39L 58.36L 1.09Cr 75Cr 1.1Cr 7.65Cr 2.94Cr 38Cr 2.96Cr 2.9Cr 121.21Cr |
| Net Debt | -5.11Cr -5.93Cr -4.84Cr -4.39Cr -8.23Cr -566.68Cr -8.27Cr -57Cr -22Cr -288.3Cr -22Cr -22Cr -911Cr | -6.59Cr -7.64Cr -6.24Cr -5.65Cr -11Cr -730.25Cr -11Cr -74Cr -28Cr -371.52Cr -29Cr -28Cr -1.17TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | €12.92 | -5.28% | 12,974 |
| 10/26/10 | €13.64 | +12.17% | 11,159 |
| 09/26/09 | €12.16 | -6.61% | 14,147 |
| 08/26/08 | €13.02 | -3.98% | 10,311 |
| 07/26/07 | €13.56 | -1.02% | 3,100 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GNFT Stock
- XUP Stock
Select your edition
All financial news and data tailored to specific country editions

















